Apex Biotechnology Corp. (1733.TW)
TWD 32.05
(-0.47%)
TWD 32.05
(-0.47%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 116.19 Million TWD | -5.28% |
| 2022 | 122.66 Million TWD | -3.91% |
| 2021 | 127.66 Million TWD | 7.93% |
| 2020 | 118.28 Million TWD | -76.69% |
| 2019 | 507.52 Million TWD | 30.73% |
| 2018 | 388.23 Million TWD | 2193.86% |
| 2017 | 16.92 Million TWD | -94.93% |
| 2016 | 333.64 Million TWD | -3.54% |
| 2015 | 345.88 Million TWD | 0.0% |
| 2014 | - TWD | -100.0% |
| 2013 | 390.15 Million TWD | 1.57% |
| 2012 | 384.11 Million TWD | 0.0% |
| 2011 | - TWD | 0.0% |
| 2010 | - TWD | 0.0% |
| 2009 | - TWD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 115.83 Million TWD | 0.0% |
| 2024 Q2 | 117.61 Million TWD | 0.0% |
| 2023 Q3 | 118.02 Million TWD | -0.72% |
| 2023 Q1 | 120.33 Million TWD | -1.9% |
| 2023 Q4 | 116.19 Million TWD | -1.55% |
| 2023 Q2 | 118.88 Million TWD | -1.21% |
| 2023 FY | 116.19 Million TWD | -5.28% |
| 2022 Q2 | 126.36 Million TWD | 0.04% |
| 2022 FY | 122.66 Million TWD | -3.91% |
| 2022 Q4 | 122.66 Million TWD | -1.74% |
| 2022 Q3 | 124.84 Million TWD | -1.2% |
| 2022 Q1 | 126.31 Million TWD | -1.06% |
| 2021 FY | 127.66 Million TWD | 7.93% |
| 2021 Q2 | 116.99 Million TWD | -0.73% |
| 2021 Q3 | 117.35 Million TWD | 0.3% |
| 2021 Q4 | 127.66 Million TWD | 8.79% |
| 2021 Q1 | 117.85 Million TWD | -0.36% |
| 2020 Q2 | 121.02 Million TWD | -76.2% |
| 2020 Q4 | 118.28 Million TWD | -1.08% |
| 2020 FY | 118.28 Million TWD | -76.69% |
| 2020 Q1 | 508.53 Million TWD | 0.2% |
| 2020 Q3 | 119.57 Million TWD | -1.19% |
| 2019 Q3 | 507.71 Million TWD | -0.02% |
| 2019 FY | 507.52 Million TWD | 30.73% |
| 2019 Q1 | 505.23 Million TWD | 30.14% |
| 2019 Q2 | 507.82 Million TWD | 0.51% |
| 2019 Q4 | 507.52 Million TWD | -0.04% |
| 2018 Q4 | 388.23 Million TWD | 0.31% |
| 2018 FY | 388.23 Million TWD | 2193.86% |
| 2018 Q3 | 387.02 Million TWD | 0.31% |
| 2018 Q2 | 385.82 Million TWD | 0.0% |
| 2018 Q1 | - TWD | 0.0% |
| 2017 Q2 | 337.2 Million TWD | 0.53% |
| 2017 FY | 16.92 Million TWD | -94.93% |
| 2017 Q4 | - TWD | 0.0% |
| 2017 Q1 | 335.42 Million TWD | 0.53% |
| 2017 Q3 | - TWD | -100.0% |
| 2016 Q2 | 331.08 Million TWD | -4.78% |
| 2016 Q1 | 347.72 Million TWD | 0.53% |
| 2016 FY | 333.64 Million TWD | -3.54% |
| 2016 Q4 | 333.64 Million TWD | 0.53% |
| 2016 Q3 | 331.88 Million TWD | 0.24% |
| 2015 Q3 | 377.05 Million TWD | 0.0% |
| 2015 Q2 | - TWD | 0.0% |
| 2015 FY | 345.88 Million TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2015 Q4 | 345.88 Million TWD | -8.27% |
| 2014 FY | - TWD | -100.0% |
| 2014 Q4 | - TWD | 0.0% |
| 2014 Q3 | - TWD | -100.0% |
| 2014 Q2 | 393.21 Million TWD | 0.39% |
| 2014 Q1 | 391.67 Million TWD | 0.39% |
| 2013 Q2 | 387.12 Million TWD | 0.39% |
| 2013 Q1 | 385.61 Million TWD | 0.39% |
| 2013 FY | 390.15 Million TWD | 1.57% |
| 2013 Q4 | 390.15 Million TWD | 0.39% |
| 2013 Q3 | 388.63 Million TWD | 0.39% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 FY | 384.11 Million TWD | 0.0% |
| 2012 Q4 | 384.11 Million TWD | 0.39% |
| 2012 Q3 | 382.61 Million TWD | 0.0% |
| 2012 Q1 | - TWD | 0.0% |
| 2011 Q2 | - TWD | 0.0% |
| 2011 Q3 | - TWD | 0.0% |
| 2011 FY | - TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 Q1 | - TWD | 0.0% |
| 2010 Q4 | - TWD | 0.0% |
| 2010 FY | - TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sinphar Pharmaceutical Co.,Ltd. | 1.49 Billion TWD | 92.223% |
| Panion & Bf Biotech Inc. | 125.41 Million TWD | 7.353% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 700 Million TWD | 83.401% |
| GenMont Biotech Incorporation | 20.11 Million TWD | -477.745% |
| Abnova (Taiwan) Corporation | 2.6 Million TWD | -4367.359% |
| Adimmune Corporation | 1.91 Billion TWD | 93.942% |
| Tanvex BioPharma, Inc. | 1.56 Billion TWD | 92.591% |
| Polaris Group | 352.96 Million TWD | 67.08% |
| Energenesis Biomedical CO.,LTD. | - TWD | -Infinity% |
| UnicoCell Biomed Co., Ltd. | 68.23 Million TWD | -70.285% |
| PELL Bio-Med Technology Co. Ltd. | 147.46 Million TWD | 21.205% |